awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q44892511-7E069B00-0F88-4C3E-A1CD-CD3A742306BC
Q44892511-7E069B00-0F88-4C3E-A1CD-CD3A742306BC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44892511-7E069B00-0F88-4C3E-A1CD-CD3A742306BC
Serum soluble interleukin-2 receptor (sIL-2R) level is associated with the outcome of patients with diffuse large B cell lymphoma treated with R-CHOP regimens.
P2860
Q44892511-7E069B00-0F88-4C3E-A1CD-CD3A742306BC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44892511-7E069B00-0F88-4C3E-A1CD-CD3A742306BC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
12f2c83569672bd09d969d4790919fdae10441e8
P2860
Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.